Neuroscience
In Vivo
100%
Emission Tomography
76%
Dopamine
56%
Atypical Antipsychotic
48%
Antipsychotic
29%
Striatum
27%
Quetiapine
27%
Amisulpride
25%
Brain
25%
Temporal Lobe
25%
Ketamine
21%
Olanzapine
20%
Risperidone
19%
Clozapine
16%
Prolactin
15%
5-HT2A Receptor
12%
Cerebellum
12%
Thalamus
11%
Frontal Lobe
10%
Major Depressive Disorder
10%
Putamen
9%
Insulin
8%
Serotonergic
8%
Tardive Dyskinesia
8%
Sertindole
8%
5-HT4 Receptor
8%
Benzodiazepine Receptor
8%
Fenfluramine
8%
Venlafaxine
8%
Sex Hormone
8%
Dopamine Receptor D3
5%
Antidepressant
5%
Statistical Parametric Mapping
5%
Occipital Lobe
5%
D2-Like Receptor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
56%
Schizophrenia
39%
Atypical Antipsychotics
25%
Iodine-123
19%
Normal Human
11%
Prospective Study
9%
Human
9%
Risperidone
8%
Drug Discovery
8%
N Methyl Dextro Aspartic Acid Receptor
8%
Tetrahydrocannabinol
8%
Medicine and Dentistry
Patient
28%
Iodine 123
17%
Antipsychotics
17%
Photon Emission Tomography
11%
Drug Action
10%
Drug Therapy
10%
Amisulpride
8%
N Methyl-D-Aspartate Receptor
8%
Epidepride
8%
Nurse
8%
Hospital
8%
Ketamine
8%
Symptom
8%
Glutamic Acid
8%
Drug
6%
Body Mass Index
5%
Weight Loss
5%
